Showing results (221-230 of 816) with videos related to

Sort By:
Pageof 82
Transplantation Proceedings|March 1, 1981
Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: implications for the mechanisms of graft-host tolerance and chronic graft-versus-host diseaseM S Tsoi, R Storb, S Dobbs, et al.
Blood|February 1, 1980
Increased in vitro B-cell IgG secretion during acute graft-versus-host disease and infection. Observations in 50 human marrow transplant recipientsO Ringden, R P Witherspoon, R Storb, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1987
Two monoclonal antibodies recognizing subpopulations of canine T lymphocytes with or without suppressor/cytotoxic functionsH J Deeg, R F Raff, E Severns, et al.
The Journal of Clinical Investigation|March 1, 1974
Canine cyclic neutropenia. A stem cell defectP L Weiden, B Robinett, T C Graham, et al.
Experimental Hematology|July 1, 1995
Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogsD S Hong, T Graham, C Ewel, et al.
Transplantation|January 15, 1995
In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cellsP Kalhs, J S White, A Gervassi, et al.
Experimental Hematology|May 1, 1983
Impaired autologous and allogeneic mixed lymphocyte reaction in human marrow transplant recipientsT Mori, M S Tsoi, S Dobbs, et al.
The New England Journal of Medicine|April 18, 1985
Subsets of patients with aplastic anemia identified by flow microfluorometryB Torok-Storb, K Doney, G Sale, et al.
The American Journal of Medicine|March 30, 1984
Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trialD J Winston, W G Ho, C H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remissionG J Schiller, S D Nimer, M C Territo, et al.
Pageof 82